glp-1 receptor agonist Comparing Ozempic, Wegovy and Other Drugs GLP-1 receptor agonists: Optimising nutritional
Description
PI, prescribing information
Dubey SK, Lakshmi KK, Krishna KV, Agrawal M, Singhvi G, Saha RN, et al
Pharmacological treatment typically begins with non-insulin antihyperglycemic agents, either as monotherapy or in combination
Of note, she previously had gastroesophageal reflux disease, but these symptoms had resolved since she started tirzepatide (Mounjaro, Eli Lilly, Indianapolis, IN) 12.5 mg/0.5 mL pen injector injection (last dose 2 days before surgery)
In addition, although numerous strategies for managing these AEs have been described, their application in clinical practice continues to evolve
